PWeR Blog
Sign up today for the latest PWeR development announcement!
The Metaverse and Healthcare – Part 2
THE METAVERSE AND HEALTHCARE – PART 2, THE UNDERLYING TECHNOLOGIES By Carl L. Larsen, President & COO, OXIO Health, Inc. In our previous blog titled, “The Changing Internet Landscape”, we introduced the concept of The Metaverse and how it is being envisioned. If you recall, the term is the marriage of two words “meta” and “verse” (taken from universe) and is used to imply something transcending the known (internet) universe. In fact, The Metaverse, is a “new domain” or a new “digital reality” that will introduce a completely new ‘culture’ and ‘ideology’, altering, even […]
READ MORE
The Metaverse and Healthcare – Part 1
THE METAVERSE AND HEALTHCARE – PART 1, THE EVER-CHANGING INTERNET LANDSCAPE Written by: Carl Larsen, PMP, MBA Recently, the term The Metaverse was officially added to the public lexicon. The term is a marriage, or portmanteau, of “meta” meaning transcending or transcendent and universe, e.g., “metaverse” or transcending the universe of the internet. Facebook® CEO, Mark Zuckerburg, recently announced that the company was changing its name to “META,” to reflect the company’s anticipated investment of over $10B in 2021 alone, to expand into The Metaverse the term was officially launched mainstream. As it turns out, The Metaverse finds […]
READ MORE
Medicare Advantage 2021 to 2035 (Part 6)
In previous blogs, we have noted that Medicare is different things to different interested parties. Whether it’s the patient or beneficiary, it is literally access to life-or-death healthcare at both of their most vulnerable financial state post-retirement, and a safety net to make sure they have access to medical care when they really need it. Additionally, it is a herculean challenge for policy makers because of the 70 million Baby Boomers in Medicare or those who are about to become eligible for Medicare as they reach age 65. New drugs […]
READ MORE
Medicare Advantage 2021 to 2035 (Part 5)
If you have been reading our previous blogs, you will have guessed that we are a big fan of the joint public/private Medicare Advantage (MA) program that is continuing to grow rapidly as part of the U.S. Medicare program. The legacy of The Center for Medicare and Medicaid (CMS) is to continue to explore and pilot new initiatives. For now, nearly 60 years into its existence, the biggest tools CMS has had were lowering reimbursement rates, bundling services creating greater value and penalizing hospital for readmissions. As we have also […]
READ MORE
Medicare Advantage 2021 to 2035 (Part 4)
In our last blog, we discussed the statistic that approximately 10,000 Americans are turning 65 daily, and the vast majority become eligible for Medicare. Additionally, we briefly explored the growing trend toward Medicare Advantage (MA) programs (Medicare funded private insurance) that provides all the benefits available to them. We have shared both historical data, charts and long-term projection for this program expected to be well north of US$600 billion early in the next decade. As of July of 2021, 28.6 million Americans were covered under a MA plan provided by […]
READ MORE
Medicare Advantage 2021 to 2035 (Part 3)
In our last two blogs, we focused our attention on discussing the growth and size of the Medicare Advantage program. Recently, a major Wall Street financial firm found the addressable market size was over $325 billion per year and the growth rate for the last 15 years has been quite impressive; however, we believe we are nowhere near the peak for the program. The title of these blogs betrays our horizon at 14 years, a point at which we think the market will stabilize as Generation X enters Medicare. Medicare […]
READ MORE
Medicare Advantage 2021 to 2035 (Part 2)
US$325,000,000,000, that’s US$325 Billion, Per Year. Did that number get your attention? A prominent New York investment bank announced that the addressable market, for one of their IPO clients in 2020, was a managed care/Medicare Advantage Management Services Organization (MSO), valued at $325 billion per year. Today, that public company is “only” doing about US$1B in revenue. According to their latest annual report, they are trading around 15 times the revenue, and earnings before interest, taxes, depreciation, and amortization (EBITDA) of nearly a negative (-) US$230 million. With the public […]
READ MORE